CVS’ acquisition of Aetna for $70B will be transformative to healthcare. A successful integration of these two prominent organizations will usher in a new healthcare model, much-needed innovation intended to lower costs and offer quality healthcare when and where patients need it.
This merger will impact healthcare supply chain and how products, from pharmaceuticals to surgical supplies, are purchased and delivered. “CVS's ability to control the benefit management, wholesale and retail distribution, and [now] be the payer, gives CVS a purchase and distribution advantage that manufacturers and providers will have to learn to how to navigate.”
For more insights on the effects of the CVS/Aetna deal, see "How CVS' $70B Aetna deal will upend supply chain operations – 5Qs with CEO John Kupice."